Olympus Stem Cells Pty Ltd are pleased to announce the provision of medical services relating to the use of stem cells for hair loss and associated alopecia conditions. The Medical Director of Olympus Stem Cells, Associate Professor Russell Vickers, has published extensively on the use of stem cells in neuropathic facial pain. He has also conducted ground breaking research and patented the use of Zinc Thymulin for hair regeneration and which was published in The Journal of Hair Therapy and Transplantation, 2017. He is now conducting clinical treatment of patients with hair loss in both males and females. More details are available at the company's website at http://www.olympusstemcells.com.au.
Associate Professor Vickers explains: "Stem Cells are extracted from abdominal wall fat following a mini liposuction procedure. The procedure is conducted under local anaesthesia and stem cells extracted following aspiration of 20-40cc's of fat. The cells and stromal vascular fraction are then injected into the scalp."
Associate Professor Vickers combines the use of topical zinc-thymulin with stem cell treatment. He has provided a more in depth explanation of the work that he does with stem cells on the clinic's website at http://www.olympushealthgroup.com.au.
Olympus Stem Cells Pty Ltd is the only company undertaking this ground breaking treatment in Australia and the Asia-Pacific region. The surgery is day stay only. Associate Professor Vickers' related research on the use of stem cells and zinc thymulin for hair regeneration are titled "An Analysis of the Safety and Efficacy of Topical Zinc-Thymulin to treat Androgenetic Alopecia" in the Hair Therapy and Transplantation journal and "The Science of Beauty. Stem Cells and cosmetic science," in the Journal of the Australian Society of Cosmetic Chemists.
The importance of such research publications is made clear at http://www.clinicalstemcells.com: "Our research is published in international peer reviewed medical and science journals (see Publications page). The research has a focus on integrating advanced stem cell techniques with established current medical treatments, and natural compounds such as the polyphenols found in plants and herbs." It is understood that Associate Professor Vickers aims to complete further research in the advancement of stem cell treatment.
Olympus Stem Cells Pty Ltd are a clinical research and development biotech company engaged in stem cell therapy in Sydney, Australia.
Olympus Stem Cell Centre,
Sydney Olympic Park,
5 Australia Avenue,
Sydney Olympic Park,
NSW, Australia.
April 12, 2018 – Olympus Stem Cells Pty Ltd Australia Demonstrating Superior Stem Cell Numbers and Viability in Treatment for Neuropathy
April 12, 2018 – Stem Cells For Hair Regeneration
April 04, 2018 – Dry Mouth from Sjogren’s Syndrome or Head and Neck Radiation: Olympus Stem Cells Advise Technical Considerations in Surgery
April 03, 2018 – Dry Eyes and Stem Cells: Olympus Stem Cells Advise Technical Considerations in Surgery
April 02, 2018 – Olympus Stem Cells Using Zinc Thymulin, Micro-Fat Grafting and Stem Cells for Baldness
April 02, 2018 – Olympus Stem Cells Using Palmitoylethanolamide (PEA) and Stem Cells for Control of Disabling Facial Neuropathic Pain
March 26, 2018 – Olympus Stem Cells Pty Ltd Highlight Relationship Between Goblet Cells, Neuropathic Pain and Post LASIK Dry Eye Syndrome
March 26, 2018 – Olympus Stem Cells Pty Ltd Highlight Relationship Between Neural Crest Cells and Neuropathic Pain in Empty Nose Syndrome
